Latest News
HaemAnalytica win at the Thames Valley Innovation and Tech Awards 2026
15 Jul 2026
HaemAnalytica won two awards at the Thames Valley Innovation and Tech Awards 2026 — Innovative Tech of the Year and Tech Start-up of the Year — recognised for cutting-edge research underpinning scalable medical technology with measurable patient outcomes.
International Day of Women and Girls in Science: Inspiring the next generation
7 Jul 2026
For International Day of Women and Girls in Science, we joined the ARC Mindset event in Manchester, inspiring girls aged 14-16 into STEM. Our COO, Gemma Little, spent the day discussing platelets and blood clotting with students — with a little help from our resident "Platelet Pal".
HaemAnalytica at BioNow Precision Medicine
7 Jul 2026
Bill and Gemma exhibited at Precision Medicine, enjoying sessions on personalised treatment approaches. TRIPLEcheck was designed to identify individuals at risk of heart attacks and strokes, and it was great to hear other exciting developments.
HaemAnalytica at BioTrinity 2026
7 Jul 2026
Chris, Jon, Bill and Jeremy attended BioTrinity 2026, with Chris presenting in the seed stage R&D session hosted by Syneos. It was a fantastic few days, and the team is already looking forward to next year's event.
HaemAnalytica receives £300,000 investment from the University of Reading
7 Jul 2026
HaemAnalytica has received a £300,000 investment from the University of Reading, where the company was spun out by Prof. Jon Gibbins and Assoc. Prof. Chris Jones. Led by CEO William Kilgallon, COO Gemma Little and CFO Jeremy Rowson, HaemAnalytica is set to revolutionise precision medicine through novel platelet assays.
Latest events
